Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults

Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis

(2016) Justin Beardsley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections

(2016) Anil A. Panackal et al.   mBio

Time to Surgery and Outcomes in Cauda Equina Syndrome: An Analysis of 45 Cases

(2016) Mohamad Bydon et al.   World Neurosurgery

Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis

(2016) Mika Komori et al.   Annals of Clinical and Translational Neurology

Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis

(2015) Mika Komori et al.   ANNALS OF NEUROLOGY

Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis

(2015) Anil A. Panackal et al.   PLoS Pathogens

Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases

(2014) S. Han et al.   JOURNAL OF IMMUNOLOGY

Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis

(2014) David R. Boulware et al.   NEW ENGLAND JOURNAL OF MEDICINE

CryptoDex: A randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial

(2014) Jeremy Day et al.   Trials

Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies Are a Risk Factor for Central Nervous System Infection by Cryptococcus gattii in Otherwise Immunocompetent Patients

(2014) T. Saijo et al.   mBio

Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes

(2013) Joseph N. Jarvis et al.   CLINICAL INFECTIOUS DISEASES

Anti-GM-CSF Autoantibodies in Patients with Cryptococcal Meningitis

(2013) L. B. Rosen et al.   JOURNAL OF IMMUNOLOGY

Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status

(2013) Kyle D. Brizendine et al.   PLoS One

Epidemiology of Cryptococcal Meningitis in the US: 1997–2009

(2013) Vasilios Pyrgos et al.   PLoS One

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis

(2012) Joseph N. Jarvis et al.   AIDS

Clinical Manifestations of Cryptococcus gattii Infection: Determinants of Neurological Sequelae and Death

(2012) Sharon C-A. Chen et al.   CLINICAL INFECTIOUS DISEASES

Cryptococcal immune reconstitution inflammatory syndrome

(2012) Nicky Longley et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant

(2012) Emily W. Bratton et al.   PLoS One

Biomarkers and surrogate endpoints in clinical trials

(2012) Thomas R. Fleming et al.   STATISTICS IN MEDICINE

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

Mechanisms of cryptococcal virulence and persistence

(2010) Michal A Olszewski et al.   Future Microbiology

Cryptococcal meningitis with severe visual and hearing loss and radiculopathy in a patient without immunodeficiency

(2010) K. Schepelmann et al.   MYCOSES

Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study

(2010) David R. Boulware et al.   PLOS MEDICINE

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Dexamethasone inCryptococcus gattiiCentral Nervous System Infection

(2009) Peter Phillips et al.   CLINICAL INFECTIOUS DISEASES